Form 8-K - Current report:
SEC Accession No. 0001564590-18-025463
Filing Date
2018-10-30
Accepted
2018-10-29 18:30:24
Documents
3
Period of Report
2018-10-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vtvt-8k_20181029.htm 8-K 21268
2 EX-99.1 vtvt-ex991_14.htm EX-99.1 8523
3 GRAPHIC gp0atpdzhb2x000001.jpg GRAPHIC 9249
  Complete submission text file 0001564590-18-025463.txt   43938
Mailing Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265
Business Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

EIN.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37524 | Film No.: 181145175
SIC: 2834 Pharmaceutical Preparations